Long intergenic non-protein coding RNA 2126 (LINC02126)

Long intergenic non-protein coding RNA 2126 (LINC02126) is a long non-coding RNA that does not encode a protein but is transcribed from intergenic genomic regions. LINC02126 has been identified as significantly downregulated in lung adenocarcinoma and has potential as a diagnostic, prognostic, and immunotherapeutic biomarker for this malignancy. Its expression correlates with several clinical variables such as tumor stage, sex, EGFR mutation status, and tumor mutation burden. Functional analysis of genes co-expressed with LINC02126 suggests involvement in gene regulation and modulation of tumor immune microenvironment, particularly influencing immune cell infiltration. LINC02126 exemplifies the broader class of lincRNAs that participate in epigenetic regulation, chromatin remodeling, and post-transcriptional control of gene expression, often with tissue-specific and disease-specific effects[1][2][5]. There is no evidence from current data that LINC02126 encodes a protein or is directly targeted by any drugs; its therapeutic interest lies in its potential as a biomarker and target for future RNA-based or immunomodulatory therapies[2][5].

Other names

LINC02126